Department of Pharmacology Archives
Reducing antidepressants’ side effects
Nov. 23, 2016—Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.
Brown named interim director of Institute of Chemical Biology
Nov. 3, 2016—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
Study finds natural compound extends lifespan of worms
Oct. 20, 2016—A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered.
Study suggests new way to treat rare autism disorder
Aug. 25, 2016—A protein that plays a powerful role in learning and memory may be a key to improving treatment of a rare autism spectrum disorder called Pitt-Hopkins syndrome (PTHS), a new study suggests.
Transcription factor evolution
Aug. 11, 2016—Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.
Possible overeating antidote
Aug. 1, 2016—The 2C-subtype of the serotonin receptor (5HT2C), which binds the neurotransmitter serotonin, plays an important role in regulating food intake and metabolism.
Drug combos for glioblastoma
May. 3, 2016—Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.
Honoring Blakely
Apr. 21, 2016—Meagan Quinlan, a Pharmacology graduate student in the laboratory of Randy Blakely, Ph.D., honored her mentor Tuesday during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall.
How strep grabs on to platelets
Apr. 20, 2016—New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.
Eye of a cytokine storm
Mar. 9, 2016—A new animal model can be used to “dissect” the inflammatory response to infection.
Schizophrenia expert Coyle set for next Flexner Discovery Lecture
Mar. 3, 2016—Joseph Coyle, M.D., an expert in the neurobiology of serious mental illness, will deliver the next Flexner Discovery Lecture on Thursday, March 10.
Grant bolsters rheumatoid arthritis research
Feb. 25, 2016—C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.
